Learn more about our Regulatory Affairs work.
Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the National Institutes of…
Vibrato Medical, an innovator in the treatment of peripheral arterial disease (PAD), announced today that it has closed a $4M Series A funding round led by the Horowitz Group, a…
Justin Klein recently joined AdvaMed® CEO Scott Whitaker for an episode of Medtech POV to talk about his expansive career in medtech and some of today’s most pressing issues across…
Learn about how recent developments in patent law affect FTO assessments.
Well-crafted tax policy on NOLs spurs innovation in new life-saving treatments and cures; and as we continue to emerge from the pandemic, there is no time more important for the…
ADVAMED EVENT — This timely webinar focused on the FDA breakthrough devices program and the implications for payment and coverage.
As medtech and the health care system drive us closer to the pandemic’s end, reflexive and ill-conceived antitrust policy targeting medical technology companies risks thwarting innovation, foreclosing patient access to…
Join us for our webinar with Sidley Austin to better understand the current health care enforcement landscape with the new administration.
President and CEO of AdvaMed® Scott Whitaker sent a letter to President Biden on behalf of the medical technology industry asking “the Administration to make the transport of medical supplies…
Join us for our webinar with Sidley Austin and China Med Device for a comprehensive overview of China’s new regulatory policies.